Cargando…
Protein Kinase CK2 and Its Potential Role as a Therapeutic Target in Huntington’s Disease
Huntington’s Disease (HD) is a devastating neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the HTT gene, for which no disease modifying therapies are currently available. Much of the recent research has focused on developing therapies to directly lower HTT expression, an...
Autores principales: | White, Angel, McGlone, Anna, Gomez-Pastor, Rocio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406209/ https://www.ncbi.nlm.nih.gov/pubmed/36009526 http://dx.doi.org/10.3390/biomedicines10081979 |
Ejemplares similares
-
Protein Kinase CK2, a Potential Therapeutic Target in Carcinoma Management
por: Lian, Haiwei, et al.
Publicado: (2019) -
Protein kinase CK2: a potential therapeutic target for diverse human diseases
por: Borgo, Christian, et al.
Publicado: (2021) -
Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
por: Spinello, Zaira, et al.
Publicado: (2021) -
CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in huntington’s disease
por: Yu, Dahyun, et al.
Publicado: (2022) -
CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders
por: Baier, Andrea, et al.
Publicado: (2022)